🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for High Risk Newly Diagnosed Multiple Myeloma

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment NCT05828511Phase 1, Phase 232 sites📍 Los Angeles📍 Orange📍 Denver Regeneron Pharmaceuticals · Tests: Linvoseltamab ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma NCT07106710Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Autologous Hematopoietic Stem Cell Transplantation, BCMA CAR-T, GPRC5D/CD3 BiTEs Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma NCT07285239Phase 31 site📍 La Crosse PrECOG, LLC. · Tests: Arm A: Belantamab Mafodotin, Arm B: Daratumumab Hyaluronidase, Bortezomib, Lenalidomide, Dexamethasone Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection NCT06409702Phase 41 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Carfilzomib, Daratumumab, Lenalidomide, Dexamethasone, VRD for first-cycle induction therapy A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma NCT06768489Phase 116 sites📍 Denver📍 Atlanta📍 Clayton Janssen Research & Development, LLC · Tests: JNJ-79635322, Daratumumab, Pomalidomide, Lenalidomide Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma NCT06407947EARLY Phase 11 site📍 Shanghai Shanghai Changzheng Hospital · Tests: Chimeric antigen receptor modified T cells Infusion Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma NCT06140966Phase 21 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Daratumumab, Carfilzomib, Lenalidomide, Dexamethasone, Cisplatin Horizon Two: HR NDMM (MMRC-100) NCT07053436Phase 212 sites📍 Duarte📍 Atlanta📍 Chicago Multiple Myeloma Research Consortium · Tests: Bispecific Monoclonal Antibody and Triplet Therapy, Monoclonal Antibody with Stem Cell Transplant A Dietary Study for People With Multiple Myeloma NCT07226609NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: nutrition counseling and coaching, dietary guidelines, research dietitian visit, Questionnaires, Frozen pre-prepared me… Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients NCT05665140Phase 2, Phase 36 sites📍 Berlin📍 Bielefeld📍 Hamburg University Hopsital Schleswig Holstein Campus Lübeck · Tests: Isatuximab, Lenalidomide, Bortezomib, Dexamethasone, autologous stem cell transplant
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy